Overview

Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

Status:
Withdrawn

Trial end date:
2017-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the essential hypertension control.

Phase:

Phase 3

Details

Lead Sponsor:

EMS

Treatments:

Candesartan
Candesartan cilexetil
Chlorthalidone
Hydrochlorothiazide
Losartan